The collagen antibody-induced arthritis model (CAIA) is an excellent alternative model for evaluating compounds for efficacy in rheumatoid arthritis. Companies no longer need to wait 42 days for results or carry special colonies as is the case in the Collagen-induced arthritis (CIA) model and the K/BxN models respectively.
Download the whitepaper to read more.